10-year ASCVD risk estimates

1. PREVENT decreases 10-year ASCVD risk estimates in humans (Risk ≥5%: PREVENT versus PCE, 9.5% versus 40.6% with male input; 9.5% versus 17.7% with female input; 8.4% versus 24.0% with female input for hormone users).

   “Use of the PREVENT calculator generates lower ASCVD risk estimates than PCE in transgender women with HIV.”

   HumansBlack and Latina transgender women with HIV; compared with PCEtransgender womensn = 108

   Cross-sectional Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Estimates in a U.S. Cohort of Black and Latina Transgender Women with HIV

   Journal of acquired immune deficiency syndromes (1999)·14 Oct 2026

More on PREVENT